16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
W9B60
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
12J45

HYQURE Biotech

About HYQURE Biotech

HYQURE focuses on biosafety testing specializing in Biologics and cell/gene therapy. As a trusted, global-compliant partner to 300+ recognized biotechs/biopharmas, we have had more than 110 successfully approved IND or BLA cases and more than 50 of them have been approved by FDA, EMA, TGA etc. The capability of methodologies and quality systems we’ve built have been recognized by global regulatory authorities. 

Certifications

Meet us at

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2025
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
Contact info
  • Building 18, Lane 2777 East Jinxiu Road,, 200120, shanghai, China

Products from HYQURE Biotech (1)

  • one-stop Biosafety Service

    Product one-stop Biosafety Service

    HyQure Biotech是一家领先的一站式生物安全服务平台,专注于大分子和CGT(细胞与基因治疗)药物。我们的核心能力包括: 1.病毒清除验证 2.细胞库特征分析 3.商业批次发布测试 4.复制适应性病毒检测(RCL、rcAAV、RCR、RCA) 5.宿主细胞蛋白/残留DNA检测套件

HYQURE Biotech Resources (1)

  • Video About HYQURE

    HYQURE focuses on biosafety testing specializing in Biologics and cell/gene therapy. As a trusted, global-compliant partner to 300+ recognized biotechs/biopharmas, we have had more than 110 successfully approved IND or BLA cases and more than 50 of them have been approved by FDA, EMA, TGA etc. The capability of methodologies and quality systems we’ve built have been recognized by global regulatory authorities.